Advertisement

Drugs & Therapy Perspectives

, Volume 2, Issue 9, pp 14–16 | Cite as

Pharmacoeconomic and QOL Analysis in Small Cell Lung Cancer

Drug Economics and Quality of Life

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Graham P, Boyages J. PharmacoEconomics 3: 446–453, 1993PubMedCrossRefGoogle Scholar
  2. 2.
    Ruckdescshel JC. Curr Opin Oncol 5: 323–334, 1993CrossRefGoogle Scholar
  3. 3.
    Fayers P. PharmacoEconomics 2: 181–188, 1992PubMedCrossRefGoogle Scholar
  4. 4.
    Medical Research Council Lung Working Party. Br J Cancer 64: 299–306, 1991CrossRefGoogle Scholar
  5. 5.
    Earl HM, et al. Br J Cancer 64: 566–572, 1991PubMedCrossRefGoogle Scholar
  6. 6.
    Medical Research Council Lung Cancer Working Party. Resp Med 83: 51–58, 1989CrossRefGoogle Scholar
  7. 7.
    Anderson H, et al. Br J Cancer 67: 1385–1390, 1993PubMedCrossRefGoogle Scholar
  8. 8.
    Goodwin PJ, et al. J Clin Oncol 6: 1537–1547, 1988PubMedGoogle Scholar
  9. 9.
    Rosenthal MA, et al. Med J Aust 156: 605–610, 1992PubMedGoogle Scholar
  10. 10.
    Faulds D, et al. PharmacoEconomics 1: 231–249, 1992PubMedCrossRefGoogle Scholar
  11. 11.
    Pashko S, Johnson DH. PharmacoEconomics 1:293–297, 1992PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Ltd 1993

Personalised recommendations